Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Annemarie Boleij, Bastiaan B.J. Tops, Paul D.M. Rombout, Elizabeth M. Dequeker, Marjolijn J.L. Ligtenberg, J. Han van Krieken, Dutch RAS EQA Initiative
Published Apr 12, 2015 · Vol. 6, No. 17 · pp. 15681-15689
Xi Feng, Frank Szulzewsky, Alexan Yerevanian, Zhihong Chen, David Heinzmann, Rikke Darling Rasmussen, Virginia Alvarez-Garcia, Yeonghwan Kim, Bingcheng Wang, Ilaria Tamagno, Hao Zhou, Xiaoxia Li, Helmut Kettenmann, Richard M. Ransohoff, Dolores Hambardzumyan
Published Mar 30, 2015 · Vol. 6, No. 17 · pp. 15077-15094
Kati Kämpjärvi, Tiina M. Järvinen, Tuomas Heikkinen, Amy S. Ruppert, Leigha Senter, Kevin W. Hoag, Olli Dufva, Mika Kontro, Laura Rassenti, Erin Hertlein, Thomas J. Kipps, Kimmo Porkka, John C. Byrd, Albert de la Chapelle, Pia Vahteristo
Published Feb 24, 2015 · Vol. 6, No. 3 · pp. 1884-1888
Keywords: Chronic lymphocytic leukemia, MED12, somatic mutation, cancer genetics, prognosis